tradingkey.logo

Metagenomi Inc

MGX
View Detailed Chart

2.250USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
84.11MMarket Cap
LossP/E TTM

Metagenomi Inc

2.250

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.17%

5 Days

-7.41%

1 Month

+34.73%

6 Months

-10.36%

Year to Date

-37.67%

1 Year

-38.02%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 6 analysts
BUY
Current Rating
10.750
Target Price
377.78%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
Metagenomi Inc
MGX
6
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Ionis Pharmaceuticals Inc
IONS
27
Exact Sciences Corp
EXAS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(5)
Neutral(3)
Buy(4)
Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.031
Neutral
RSI(14)
56.100
Neutral
STOCH(KDJ)(9,3,3)
26.613
Sell
ATR(14)
0.240
Low Volatility
CCI(14)
-32.640
Neutral
Williams %R
68.966
Sell
TRIX(12,20)
1.510
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
2.337
Sell
MA10
2.351
Sell
MA20
2.219
Buy
MA50
1.840
Buy
MA100
1.720
Buy
MA200
2.128
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed an expansive and modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. Its platform enables it to rapidly and effectively find, screen, and select tools with the highest targetability, specificity, and efficiency in order to develop them into genetic medicine.
Ticker SymbolMGX
CompanyMetagenomi Inc
CEODr. Brian C. Thomas, Ph.D.
Websitehttps://metagenomi.co/
KeyAI